检索结果-南通市图书馆

Effect of resistance training volume on body adiposity,metabolic risk,and inflammation in postmenopausal and older females:Systematic review and meta-analysis of randomized controlled trials

引用

Journal of Sport and Health Science 2024年第2期13卷 145-159页

作者： Paulo Ricardo Prado Nunes Pamela Castro-e-Souza Anselmo Alves de Oliveira Bruno de Freitas Camilo Gislaine Cristina-Souza Lucio Marques Vieira-Souza marcelo Augusto da silva Carneiro Department of Body and Human Movement Minas Gerais State University(UEMG)37902-092 PassosMGBrazil University Center of Planalto de Araxa(UNIARAXA) 38180-129 AraxaMGBrazil Physical Activity Health and Ageing Research Group(GPASE)Minas Gerais State University(UEMG)37902-092 PassosMGBrazil Exercise and Nutrition Research Group(GPEN) Minas Gerais State University(UEMG)37902-092 PassosMGBrazil Sport Sciences and Physical Exercise Study and Research Group(GEPCEEX) Minas Gerais State University(UEMG)37902-092 PassosMGBrazil Metabolism Nutrition and Exercise LaboratoryPhysical Education and Sport CenterLondrina State University(UEL)86050-070 LondrinaPRBrazil Postgraduate Program in Physical Education Federal University of Sergipe(UFS)49107-230 Sao CristovaoSEBrazil

Purpose:This meta-analytical study aimed to explore the effects of resistance training(RT) volume on body adiposity,metabolic risk,and inflammation in postmenopausal and older ***:A systematic search was performed for randomized controlled trials in PubMed,Scopus,Web of Science,and *** controlled trials with postmenopausal and older females that compared RT effects on body adiposity,metabolic risk,and inflammation with a control group(CG) were *** reviewers selected the studies,extracted the data,and performed the risk of bias and certainty of the evidence(Grading of Recommendations,Assessment,Development,and Evaluation(GRADE)) *** body and abdominal adiposity,blood lipids,glucose,and C-reactive protein were included for meta-analysis.A random-effects model,standardized mean difference(Hedges’ g),and 95% confidence interval(95%CI) were used for ***:Twenty randomized controlled trials(overall risk of bias:some concerns;GRADE:low to very low) with overweight/obese postmenopausal and older females were *** groups were divided into low-volume RT(LVRT,~44 sets/week) and high-volume RT(HVRT,~77 sets/week).Both RT groups presented improved body adiposity,metabolic risk,and inflammation when compared to ***,HVRT demonstrated higher effect sizes than LVRT for glucose(HVRT=-1.19;95%CI:-1.63 to-0.74;LVRT=-0.78;95%CI:-1.15 to-0.41) and C-reactive protein(HVRT=-1.00;95%CI:-1.32 to-0.67;LVRT=-0.34;95%CI,-0.63 to-0.04)) when compared to ***:Compared to CG,HVRT protocols elicit greater improvements in metabolic risk and inflammation outcomes than LVRT in overweight/obese postmenopausal and older females.

关键词： C-reactive protein Fat mass Lipid profile Menopause Strength training

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors

引用

World Journal of Gastroenterology 2020年第16期26卷 1888-1900页

作者： Federico Pinero marcelo silva Massimo Iavarone Hospital Universitario Austral Facultad de Ciencias BiomédicasUniversidad AustralBuenos Aires B1629HJArgentina Latin American Liver Research Educational and Awareness Network Buenos Aires B1629HJArgentina Division of Gastroenterology and Hepatology CRC“A.M.e A.Migliavacca”Center for the Study of Liver DiseaseUniversity of MilanFondazione IRCCS Ca’Granda Maggiore HospitalMilan 20121Italy

During the last decades,further knowledge of hepatocellular carcinoma(HCC)molecular mechanisms has led to development of effective systemic treatments including tyrosine kinase inhibitors(TKIs)and *** this review,we describe first and second line systemic treatment options for advanced *** trials have evaluated new drugs for the treatment of HCC patients:In first line,lenvatinib resulted non-inferior to sorafenib and it can be used as alternative,even in the lack of evidence for sequential treatment options in second line after ***,atezolizumab plus bevacizumab have shown superiority over sorafenib in ***-regorafenib sequential administration in selected patients has opened a new paradigm of treatment in advanced HCC with a life expectancy exceeding two *** TKIs for second line treatment include cabozantinib and ramucirumab(specifically for patients with Alpha-fetoprotein values≥400 ng/mL).The combination of TKIs with immunotherapy may represent a big step forward for these patients in the near future.

关键词： Hepatocellular carcinoma Systemic Options Sequencing Advanced Future

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges

引用

World Journal of Gastroenterology 2018年第37期24卷 4224-4229页

作者： Federico Pinro Jaime Poniachik Ezequiel Ridruejo marcelo silva Hospital Universitario Austral Facultad de Ciencias BiomédicasUniversidad AustralPilarBuenos Aires B1629HJArgentina American Liver Research Educational and Awareness Network Buenos Aires B1629HJArgentina Hepatology Hospital Clínico Universidad de ChileSantiago de ChileRegión Metropolitana Santiago 46010Chile Santa María Santiago de ChileRegión Metropolitana Santiago 834-0518Chile Médica e Investigaciones Clínicas Norberto Quirno Ciudad de Buenos Aires C1425ASGArgentina

Latin America, a region with a population greater than 600000000 individuals, is well known due to its wide geographic, socio-cultural and economic heterogeneity. Access to health care remains as the main barrier that challenges routine screening, early diagnosis and proper treatment of hepatocellular carcinoma(HCC). Therefore, identification of population at risk, implementation of surveillance programs and access to curative treatments has been poorly obtained in the region. Different retrospective cohort studies from the region have shown flaws in the implementation process of routine surveillance and early HCC diagnosis. Furthermore, adherence to clinical practice guidelines recommendations assessed in two studies from Brazil and Argentina demonstrated that there is also room for improvement in this field, similarly than the one observed in Europe and the United States. In summary, Latin America shares difficulties in HCC decision-making processes similar to those from developed countries. However, a transversal limitation in the region is the poor access to health care with the consequent limitation to standard treatments for overall population. Specifically, universal health care access to the different World Health Organization levels is crucial, including improvement in research, education and continuous medical training in order to expand knowledge and generation of data promoting a continuous improvement in the care of HCC patients.

关键词： Latin America Liver cancer Limitations Challenge

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Assessment of hybrid geoids in Chile and Spain,combining GGM and GNSS/Leveling observations

引用

Geodesy and Geodynamics 2021年第2期12卷 65-92页

作者： Jose Antonio Tarrio Mosquera marcelo Caverlotti silva Fernando Isla Carlos Prado University of Santiago of Chile(USACH) Faculty of EngineeringGeographical Engineering DepartmentChile Geographic Military Institute Chile

This research presents the results for analyses done to five geopotential global models(GGM),comparing them with ground data from GNSS and leveling in heterogenic zones from the geodetic perspective,in Chile and *** the official and complete implementation of the International Height Reference Frame(IHRF)has not yet been established,the vertical geodetic system of many countries is not calculated on a global scale;instead,it is calculated by the variation of relative heights between one or more local tide gauges,such as in the case of Spain and *** aspect creates regional and specific altimetry data,which disables the use of GGM to directly obtain the orthometric height of the vertical reference system(VRS)from the GNSS *** models currently reach centimetric precision due to their high resolution but are directly incompatible for a local *** solve this,we expose in this article the contrast between geometric geoidal undulation(ellipsoidal heights and orthometric data from the leveling networks in Spain and Chile)with the geoidal undulation in more recent models and higher resolution:Earth Gravitational Model 2008(EGM08),European Improved Gravity model of the Earth by New techniques(EIGEN6 C4),Gravity Observation Combination(GOCO05 C),Experimental Gravity Field Model(XGM2016),and Ultra-High Resolution Global Geopotential Model(SGG-UGM),adjusting the residual between both referential heights by different parametric models and polynomials of determined *** evaluated,their geoidal undulations are combined with GNSS/leveling data from the corresponding VRS to generate a correcting surface,which is also known as a hybrid geoid,resulting in a model of optimal adjustment for the combination of five parameters of the EIGEN-6 C4 with orthometric heights and ellipsoids of both Chile and *** results show 2-3 cm precisions,which were statistically analyzed to determine the suitability for *** final products are three grids of indep

关键词： GNSS levelling Correcting surface IHRS SIRGAS EIGEN-6C4

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation:Is the current evidence applicable to these patients?

引用

World Journal of Transplantation 2020年第11期10卷 297-306页

作者： Federico Piñero Marcos Thompson Juan Ignacio Marín marcelo silva Hepatology and Liver Transplant Unit Hospital Universitario AustralBuenos Aires B1629HJArgentina Hospital Universitario Austral Facultad de Ciencias BiomédicasUniversidad AustralBuenos Aires B1629HJArgentina Latin American Liver Research Educational and Awareness Network(LALREAN) Buenos Aires B1629HJArgentina Hepatology and Liver Transplantation Unit Hospital Pablo Tobón UribeMedellín 240Colombia

Liver transplantation(LT)is one of the leading curative therapies for hepatocellular carcinoma(HCC).Despite recent optimization of transplant selection criteria,including alpha-feto protein,HCC recurrence after LT is still the leading cause of death in these *** the last decades,effective systemic treatments for HCC,including tyrosine kinase inhibitors and immunotherapy,have been *** describe the clinical scenario of a patient with recurrence of HCC five years after LT,who received lenvatinib as first-line systemic therapy to introduce systemic treatment options in this clinical *** this opinion review,we detail first and second-line systemic treatment options,focusing on those feasible for patients with recurrent HCC after *** trials have evaluated new drugs to treat HCC patients in first and secondline therapy,but patients with recurrent HCC after LT have been excluded from these ***,most of the evidence comes from observational retrospective *** tyrosine kinase inhibitors will remain the primary therapeutic approach in these patients,due to a relative contraindication for immunotherapy,may be clarified in the near future.

关键词： Liver transplantation Recurrence Systemic therapies Hepatocellular carcinoma

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Impacted Lower Third Molar Fused with a Supernumerary Tooth—Diagnosis and Treatment Planning Using Cone-Beam Computed Tomography

引用

International Journal of Oral Science 2009年第4期1卷 224-228页

作者： Osny Ferreira-Junior Luciana Dorigatti de .＆.Aila marcelo Bonifacio da silva Sampieri Eduardo Dias- Ribeiro Wei-liang Chen Song Fan Department of Stomatology Dental School of Bauru University of Sao Paulo Bauru Sao Paulo Brazil Department of Stomatology the Second Affiliated Hospital Sun Yat-Sen University Guangzhou China

This paper reported a case of fusion between an impacted third molar and a supernumerary tooth, in which a surgical intervention was carried out, with the objective of removing the dental elements. The panoramic radiography was complemented by the Donovan＇s radiographic technique; but because of the proximity of the dental element to the mandibular ramus, it was not possible to have a final fusion diagnosis. Hence, the Cone-Beam Computed Tomography--which provides precise three- dimensional information--was used to determinate the fusion diagnosis and also to help in the surgical planning. In this case report we observed that the periapical, occlusal and panoramic were not able to show details which could only be examined through the cone-beam computed tomo- graphy.

关键词： third molar supernumerary tooth oral surgery,cone-beam computed tomography

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Liver transplantation in acute liver failure:A challengingscenario

引用

World Journal of Gastroenterology 2016年第4期22卷 1523-1531页

作者： Manuel Mendizabal marcelo Oscar silva Hepatology and Liver Transplant Unit Hospital Universitario AustralPilar B1629AHJArgentina

Acute liver failure is a critical medical condition defined as rapid development of hepatic dysfunction associated with encephalopathy. The prognosis in these patients is highly variable and depends on the etiology, intervalbetween jaundice and encephalopathy, age, and the degree of coagulopathy. Determining the prognosis for this population is vital. Unfortunately, prognostic models with both high sensitivity and specificity for prediction of death have not been developed. Liver transplantation has dramatically improved survival in patients with acute liver failure. Still, 25% to 45% of patients will survive with medical treatment. The identification of patients who will eventually require liver transplantation should be carefully addressed through the combination of current prognostic models and continuous medical assessment. The concerns of inaccurate selection for transplantation are significant, exposing the recipient to a complex surgery and lifelong immunosuppression. In this challenging scenario, where organ shortage remains one of the main problems, alternatives to conventional orthotopic liver transplantation, such as living-donor liver transplantation, auxiliary liver transplant, and ABO-incompatible grafts, should be explored. Although overall outcomes after liver transplantation for acute liver failure are improving, they are not yet comparable to elective transplantation.

关键词： Encephalopathy Fulminant hepatic failure Liver transplantation Outcome Prognostic score

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Heterogeneity in the Second Internal Transcribed Spacer (ITS2) of rDNA in the Genetically Distinct Metopolophium dirhodum Isofemale Lineages (Hemiptera: Aphididae)

引用

Advances in Entomology 2014年第4期2卷 194-201页

作者： marcelo Lopes-da-silva Luiz Gonzaga Esteves Vieira Plant Quarantine Laboratory Embrapa Genetic Resources and Biotechnology Brazilian Agriculture Research Corporation (Embrapa) Brasília DF Brazil University of Western São Paulo (Unoeste) Presidente Prudente Brazil

The aim of this study was to investigate the level of evolutionary divergence among five isofemale lineages of Metopolophium dirhodum Walker (Hemiptera: Aphididae) using sequences of the Internal Transcribed Spacer (ITS) of ribosomal DNA (rDNA). These isofemalelineages were derived from parthenogenetic females, previously genetically characterized by having strong association of RAPD (Random Amplified Polymorphic DNA) molecular markers and host plant preference. Out of 25 sequences, only 17 containing ITS2 (the second spacer) were used for analysis due to their quality. Within 250 nucleotide sites originated by multiple alignments, 10.4% were variable, with the predominance of indels over substitutions. The average of nucleotide diversity (π) within isofemale lineages was similar to the diversity found among all isofemale lineages. The topology inferred by the Neighbor-Joining method showed that no evolutionary divergence inferred by ITS2 sequences among isofemale lineages typified by RAPD could be associated with host preference. The ITS2 sequence differences found within lineages and their causes are discussed.

关键词： Aphid Clones Molecular Evolution DNA

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Chagas heart disease:An overview of diagnosis,manifestations,treatment,and care

引用

World Journal of Cardiology 2021年第12期13卷 654-675页

作者： Roberto M Saraiva Mauro Felippe F Mediano Fernanda SNS Mendes Gilberto marcelo Sperandio da silva Henrique H Veloso Luiz Henrique C Sangenis Paula Simplício da silva Flavia Mazzoli-Rocha Andréa S Sousa marcelo T Holanda Alejandro M Hasslocher-Moreno Evandro Chagas National Institute of Infectious Diseases Oswaldo Cruz FoundationRio de Janeiro 21040-900RJBrazil

Chagas heart disease(CHD)affects approximately 30%of patients chronically infected with the protozoa Trypanosoma *** is classified into four stages of increasing severity according to electrocardiographic,echocardiographic,and clinical *** presents with a myriad of clinical manifestations,but its main complications are sudden cardiac death,heart failure,and ***,CHD has a higher incidence of sudden cardiac death and stroke than most other cardiopathies,and patients with CHD complicated by heart failure have a higher mortality than patients with heart failure caused by other *** patients with CHD,approximately 90%of deaths can be attributed to complications of Chagas *** cardiac death is the most common cause of death(55%–60%),followed by heart failure(25%–30%)and stroke(10%–15%).The high morbimortality and the unique characteristics of CHD demand an individualized approach according to the stage of the disease and associated complications the patient presents ***,the management of CHD is challenging,and in this review,we present the most updated available data to help clinicians and cardiologists in the care of these *** describe the clinical manifestations,diagnosis and classification criteria,risk stratification,and approach to the different clinical aspects of CHD using diagnostic tools and pharmacological and non-pharmacological treatments.

关键词： Chagas disease Diagnosis Treatment Heart failure Arrhythmia Stroke

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Intermediate-advanced hepatocellular carcinoma in Argentina:Treatment and survival analysis

引用

World Journal of Gastroenterology 2019年第27期25卷 3607-3618页

作者： Federico Pinero Sebastián Marciano Nora Fernández Jorge silva Margarita Anders Alina Zerega Ezequiel Ridruejo Gustavo Romero Beatriz Ameigeiras Claudia D’Amico Luis Gaite Carla Bermúdez Virginia Reggiardo Luis Colombato Adrián Gadano marcelo silva Hospital Universitario Austral Facultad de Ciencias BiomédicasUniversidad AustralBuenos Aires B1629HJArgentina Latin American Liver Research Educational and Awareness Network(LALREAN) Buenos Aires B1629HJArgentina Hospital Italiano de Buenos Cuidad Autónoma de Buenos AiresBuenos Aires C1424BYEArgentina Hospital Británico Cuidad Autonoma de Buenos AiresBuenos Aires C1280AEBArgentina Hospital G Rawson San Juan 5400Argentina Hospital Aleman Cuidad Autonoma de Buenos AiresBuenos Aires C1280AEBArgentina Sanatorio Allende from Córdoba Córdoba 5016Argentina Centro de Educación Médica e Investigaciones Clínicas“Norberto Quirno”(CEMIC) Ciudad de Buenos Aires 1431Argentina Hospital Udaondo Cuidad Autonoma de Buenos Aires C1264AAAArgentina Hospital Ramos Mejía Ciudad de Buenos Aires C1221ADCArgentina Centro Especialidades Medicas Ambulatorias(CEMA) Mar del PlataBuenos Aires 7600Argentina Clínica de Nefrología Santa Fe 3000Argentina Hospital del Centenario RosarioSanta Fe S2002KDTArgentina

BACKGROUND Hepatocellular carcinoma(HCC) represents the sixteenth most frequent cancer in Argentina. The rise of new therapeutic modalities in intermediate-advanced HCC opens up a new paradigm for the treatment of *** To describe real-life treatments performed in patients with intermediateadvanced HCC before the approval of new systemic *** This longitudinal observational cohort study was conducted between 2009 and2016 in 14 different regional hospitals from Argentina. Included subjects had intermediate-advanced Barcelona Clinic Liver Cancer(BCLC) HCC stages(BCLC B to D). Primary end point analyzed was survival, which was assessed for each BCLC stage from the date of treatment until last patient follow-up or *** Meier survival curves and Cox regression analysis were performed, with hazard ratios(HR) calculations and 95% confidence intervals(95%CI).RESULTS From 327 HCC patients, 41% were BCLC stage B, 20% stage C and 39% stage *** median survival were 15 mo(IQR 5-26 mo), 5 mo(IQR 2-13 mo)and 3 mo(IQR 1-13 mo)(P < 0.0001), respectively. Among BCLC-B patients(n =135), 57% received TACE with a median number of 2 sessions(IQR 1-3 sessions).Survival was significantly better in BCLC-B patients treated with TACE HR =0.29(CI: 0.21-0.40) than those without TACE. After tumor reassessment by RECIST 1.1 criteria following the first TACE, patients with complete response achieved longer survival (HR = 0.15(CI: 0.04-0.56, P = 0.005))Eighty-two patients were treated with sorafenib, mostly BCLC-B and C(87.8%). However,12.2% were BCLC-D. Median survival with sorafenib was 4.5 mo(IQR 2.3-11.7 mo);which was lower among BCLC-D patients 3.2 mo(IQR 2.0-14.1 mo). A total of 36 BCLC-B patients presented tumor progression after TACE. In these patients,treatment with sorafenib presented better survival when compared to those patients who received sorafenib without prior TACE [HR = 0.26(CI: 0.09-0.71);P= 0.013].CONCLUSION In this real setting, our results we

关键词： Hepatocellular carcinoma Therapeutics Survival Real-life

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：